<DOC>
	<DOCNO>NCT01895140</DOCNO>
	<brief_summary>The purpose study evaluate clinical economic impact implementation renal denervation Symplicity™ Catheter System treatment-resistant hypertension Ontario , Canada .</brief_summary>
	<brief_title>A Study Renal Denervation Patients With Treatment Resistant Hypertension</brief_title>
	<detailed_description>This pragmatic randomized trial renal nerve denervation treatment resistant hypertension . This part ministry sponsor MaRS-EXCITE program , conduct early market health technology assessment , order determine appropriateness provincial funding . We assess effectiveness , safety , economic attractiveness feasibility implementation renal nerve denervation treatment resistant hypertension . This involve new model care include multi-disciplinary team approach patient . Treatment resistant hypertension define patient uncontrolled hypertension despite optimal dos 3 anti-hypertensive medication . Patients randomize either standard treatment renal nerve denervation follow 6 month determine impact blood pressure .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Ontario resident Aged 18 Diagnosis treatmentresistant hypertension assessment optimization hypertension specialist follow recommended evaluation diagnosis outline American Heart Association Office systolic blood pressure ≥ 160 mmHg ( ≥ 150 mmHg patient type II diabetes mellitus ) prior optimization hypertension specialist Baseline average systolic 24 hour ambulatory blood pressure ≥ 135 mmHg optimization prior randomization Prescribed 3 antihypertensive medication different class , prior optimization randomization , one must diuretic ( medication count act different receptor ) Suitable renal artery anatomy base CT/MRI/renal angiography imaging : renal artery &gt; 20 mm length &gt; 4 mm diameter without significant fibromuscular disease renal artery stenosis ( &gt; 50 % ) Secondary cause hypertension : 1 . Primary aldosteronism ( secondary adrenal adenoma ) 2 . Chronic kidney disease : creatinine clearance eGFR &lt; 45 ml/min/1.73m² ( measure 24 hour urine preferably MDRD ) 3 . Pheochromocytoma 4 . Cushing 's syndrome 5 . Aortic coarctation ( differential brachial femoral pulse , systolic bruit ) Type 1 diabetes mellitus Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Treatment-resistant hypertension</keyword>
	<keyword>Renal denervation</keyword>
	<keyword>Ambulatory blood pressure</keyword>
</DOC>